Fellowship · Washington, DC
Sponsored by George Washington University School of Medicine
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
Circulation · 2023 · 1,648 citations · Janani Rangaswami
Development and Validation of the American Heart Association's PREVENT Equations.
Circulation · 2024 · 976 citations · Janani Rangaswami
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.
Circulation · 2023 · 1,080 citations · Janani Rangaswami
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
Circulation · 2023 · 630 citations · Janani Rangaswami
Metabolic syndrome.
Nature reviews. Disease primers · 2024 · 341 citations · Janani Rangaswami
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet (London, England) · 2021 · 623 citations · Dominic Raj
Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53.
Cardiovascular diabetology · 2024 · 93 citations · Pedro Jose
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
Journal of the American Society of Nephrology : JASN · 2022 · 119 citations · Nicolas Guzman